Muenchbach Martin 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Sep 14, 2007
Insider Transaction Report
Form 4
Muenchbach Martin
Director
Transactions
- Award
Common Stock
2007-09-12+2,500→ 2,500 total
Holdings
- 1,025,624(indirect: by BB Biotech Ventures II, L.P.)
Common Stock
Footnotes (1)
- [F1]Dr. Muenchbach is employed as an investment manager at Swissfirst Asset Management AG, which manages BB Biotech Ventures II, L.P.. Dr. Muenchbach disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial owenership of all of the reported shares for purposes of Section 16 or any other purpose.